Gastrointestinal Neoplasms: all 795 studies

Page 3 of 8. Open to participants first (235), then studies with results posted, then the rest; newest registration first within each.

• Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesRecruitingNCT04899908Phase 2
• Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesRecruitingNCT04847063Phase 1
• Rare Subtypes of Gastrointestinal CancersRecruitingNCT04838327
• EUS Guided HVA and PVA for Circulating Tumor DNA in PatientsRecruitingNCT04782557Not applicable
• CART Therapy in Digestive System TumorsNot yet recruitingNCT04780529Not applicable
• SGM-101 in Colorectal Brain Metastases.RecruitingNCT04755920Phase 2
• Multicomponent Prehabilitation and Outcomes in Elderly Patients With FrailtyRecruitingNCT04715581Not applicable
• The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled StudyRecruitingNCT04700527Phase 1/2
• Resilience and Equity in Aging, Cancer, and Health (REACH)RecruitingNCT04674267Not applicable
• Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal CancersRecruitingNCT04629677
• PD-L1 Targeting Molecular Imaging of Solid TumorsRecruitingNCT04629326Not applicable
• MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy OutcomesRecruitingNCT04534543Not applicable
• Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast CancerRecruitingNCT04530890Not applicable
• OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.RecruitingNCT04493632
• FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction AdenocarcinomaRecruitingNCT04393584Phase 2/3
• Interaction Between Host, Microenvironment and Immunity on Gastrointestinal NeoplasmsRecruitingNCT04363983Not applicable
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
• Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine CarcinomasRecruitingNCT04268121Phase 2
• Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
• A Clinicobiological Database in Metastatic Digestive CancersRecruitingNCT03978078Not applicable
• OH2 Oncolytic Viral Therapy in Solid TumorsRecruitingNCT03866525Phase 1/2
• 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal CancersRecruitingNCT03800693Phase 2
• Genomic Investigation of Unusual RespondersRecruitingNCT03740503
• Immunotherapy Treating GI CancerNot yet recruitingNCT03614650Phase 1/2
• A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRCRecruitingNCT03303495Phase 3
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsRecruitingNCT03190941Phase 1/2
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/2
• Ontario-wide Cancer TArgeted Nucleic Acid EvaluationRecruitingNCT02906943
• Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract CancerEnrolling by invitationNCT02428101
• Los Angeles Prospective GI Biliary and EUS SeriesRecruitingNCT02196935
• Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal LesionsRecruitingNCT01750619
• Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal CancerRecruitingNCT01313442
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
• Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT00068003
• Ketamine-assisted Therapy for Advanced GI CancerTerminatedNCT06077487Phase 4Results posted
• Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI CancersTerminatedNCT06001372Early Phase 1Results posted
• Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2TerminatedNCT05980416Phase 1Results posted
• Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersCompletedNCT05641896Phase 2Results posted
• Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and AnastomosisCompletedNCT05320029Not applicableResults posted
• Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) MalignanciesTerminatedNCT05221320Phase 2Results posted
• A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)TerminatedNCT05160168Phase 1/2Results posted
• A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal CancersCompletedNCT05087992Phase 1Results posted
• A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid TumorsCompletedNCT05001347Phase 2Results posted
• Perioperative Telemonitoring to Optimize Cancer Care and OutcomesActive, not recruitingNCT04986566Not applicableResults posted
• Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or HypnotherapyTerminatedNCT04899492Not applicableResults posted
• Implementing Pharmacogenetic Testing in Gastrointestinal CancersCompletedNCT04736472Not applicableResults posted
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsTerminatedNCT04644315Phase 2Results posted
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT04607421Phase 3Results posted
• Impact Of Nurse Navigation Program on Outcomes in Patients With GI CancersCompletedNCT04602611Not applicableResults posted
• Improving Cancer On-treatment Symptom ManagementCompletedNCT04589247Results posted
• Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryTerminatedNCT04588246Phase 3Results posted
• Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerCompletedNCT04505553Phase 2Results posted
• Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative ResectionCompletedNCT04457297Phase 3Results posted
• Prevention of Colorectal Cancer Through Multiomics Blood TestingCompletedNCT04369053Results posted
• Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced MalignanciesTerminatedNCT04214418Phase 1/2Results posted
• Cabozantinib and Nivolumab for Carcinoid TumorsCompletedNCT04197310Phase 2Results posted
• Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.TerminatedNCT04171141Phase 1Results posted
• A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal CancerCompletedNCT04137289Phase 1Results posted
• Telephone Support for Advanced Gastrointestinal Cancer Patients and CaregiversCompletedNCT04010227Not applicableResults posted
• Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCCompletedNCT03989115Phase 1/2Results posted
• Symptom Management Implementation of Patient Reported Outcomes in OncologyCompletedNCT03850912Not applicableResults posted
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 PatientsTerminatedNCT03745326Phase 1/2Results posted
• Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)CompletedNCT03723447Phase 4Results posted
• Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family MembersCompletedNCT03611309Not applicableResults posted
• A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerCompletedNCT03535727Phase 1/2Results posted
• Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion PhaseCompletedNCT03531320Phase 1/2Results posted
• Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric CancersTerminatedNCT03515941Early Phase 1Results posted
• Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerTerminatedNCT03480152Phase 1/2Results posted
• A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)TerminatedNCT03449030Phase 1Results posted
• BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalCompletedNCT03367247Not applicableResults posted
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerCompletedNCT03362177Phase 3Results posted
• Bridge: Proactive Psychiatry Consultation and Case Management for Patients With CancerCompletedNCT03360695Not applicableResults posted
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal CancerCompletedNCT03343301Phase 1Results posted
• Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary CancerActive, not recruitingNCT03337087Phase 1/2Results posted
• DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]CompletedNCT03329690Phase 2Results posted
• Hydrogel Injection to Assist Endoscopic Submucosal DissectionCompletedNCT03321396Not applicableResults posted
• Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous CancerTerminatedNCT03300843Phase 2Results posted
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/2Results posted
• Cerebral Blood Flow During Propofol AnaesthesiaCompletedNCT02951273Results posted
• Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 MicrospheresTerminatedNCT02859064Phase 2Results posted
• A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerCompletedNCT02795988Phase 1/2Results posted
• Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced CholangiocarcinomaCompletedNCT02631590Phase 2Results posted
• Evaluating Strategies to Present Colon Cancer Screening InformationCompletedNCT02485561Not applicableResults posted
• AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant AscitesTerminatedNCT02417753Phase 2Results posted
• Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing SurgeryCompletedNCT02356471Not applicableResults posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02259725Phase 2Results posted
• Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI CancersTerminatedNCT02241720Phase 2Results posted
• The Laparotomy StudyCompletedNCT02140593Phase 4Results posted
• A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam RadiotherapyCompletedNCT02130427Not applicableResults posted
• Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric CancerCompletedNCT02092298Phase 2Results posted
• A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal CancerCompletedNCT02024607Phase 1/2Results posted
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)CompletedNCT01964430Phase 3Results posted
• Abraxane in CIMP-High Colorectal and Small Bowel AdenocarcinomasCompletedNCT01730586Phase 2Results posted
• 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerCompletedNCT01658813Phase 2Results posted
• A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyCompletedNCT01624220Not applicableResults posted
• Mithramycin for Lung, Esophagus, and Other Chest CancersTerminatedNCT01624090Phase 2Results posted
• Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination ChemotherapyCompletedNCT01504711Not applicableResults posted
• Proton Radiotherapy for Upper Gastrointestinal MalignanciesCompletedNCT01449864Not applicableResults posted

← Gastrointestinal Neoplasms overview